Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 649

1.

Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy.

Hatano H, Delwart EL, Norris PJ, Lee TH, Dunn-Williams J, Hunt PW, Hoh R, Stramer SL, Linnen JM, McCune JM, Martin JN, Busch MP, Deeks SG.

J Virol. 2009 Jan;83(1):329-35. doi: 10.1128/JVI.01763-08. Epub 2008 Oct 22.

2.

Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load.

Kostrikis LG, Touloumi G, Karanicolas R, Pantazis N, Anastassopoulou C, Karafoulidou A, Goedert JJ, Hatzakis A; Multicenter Hemophilia Cohort Study Group.

J Virol. 2002 Oct;76(20):10099-108.

3.

Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects.

Anton PA, Mitsuyasu RT, Deeks SG, Scadden DT, Wagner B, Huang C, Macken C, Richman DD, Christopherson C, Borellini F, Lazar R, Hege KM.

AIDS. 2003 Jan 3;17(1):53-63.

PMID:
12478069
4.

Virological characterization of patients treated early is able to control HIV-1 replication after multiple cycles of structured therapy interruption.

Rozera G, Abbate I, D'Offizi G, Corpolongo A, Narciso P, Vlassi C, Martini F, Calcaterra S, Capobianchi MR.

J Med Virol. 2007 Aug;79(8):1047-54.

PMID:
17597482
5.

CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.

Khanna N, Opravil M, Furrer H, Cavassini M, Vernazza P, Bernasconi E, Weber R, Hirschel B, Battegay M, Kaufmann GR; Swiss HIV Cohort Study.

Clin Infect Dis. 2008 Oct 15;47(8):1093-101. doi: 10.1086/592113. Erratum in: Clin Infect Dis. 2009 May 15;48(10):1491.

6.

Undetectable viremia without antiretroviral therapy in patients with HIV seroconversion: an uncommon phenomenon?

Madec Y, Boufassa F, Rouzioux C, Delfraissy JF, Meyer L; SEROCO Study Group.

Clin Infect Dis. 2005 May 1;40(9):1350-4. Epub 2005 Mar 31.

PMID:
15825038
7.

Cellular HIV-1 DNA quantitation in patients during simplification therapy with protease inhibitor-sparing regimens.

Sarmati L, Parisi SG, Nicastri E, d'Ettorre G, Andreoni C, Dori L, Gatti F, Montano M, Buonomini AR, Boldrin C, Palù G, Vullo V, Andreoni M.

J Med Virol. 2007 Jul;79(7):880-6.

PMID:
17516532
8.

Long-term evolution of CD4 count in patients with a plasma HIV RNA persistently <500 copies/mL during treatment with antiretroviral drugs.

Le Moing V, Thiébaut R, Chêne G, Sobel A, Massip P, Collin F, Meyohas M, Al Kaïed F, Leport C, Raffi F; ANRS CO8 (APROCO/COPILOTE) Study Group.

HIV Med. 2007 Apr;8(3):156-63.

9.

Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy.

Harrigan PR, Whaley M, Montaner JS.

AIDS. 1999 May 28;13(8):F59-62.

PMID:
10371167
10.

Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infection.

Lefrère JJ, Morand-Joubert L, Mariotti M, Bludau H, Burghoffer B, Petit JC, Roudot-Thoraval F.

Blood. 1997 Aug 1;90(3):1133-40.

11.

HIV-2-infected individuals with undetectable plasma viremia carry replication-competent virus in peripheral blood lymphocytes.

Blaak H, Boers PH, Schutten M, van der Endeñ ME, Osterhaus AD.

J Acquir Immune Defic Syndr. 2004 Jul 1;36(3):777-82.

PMID:
15213560
12.

Virus burden in lymph nodes and blood of subjects with primary human immunodeficiency virus type 1 infection on bitherapy.

Perrin L, Yerly S, Marchal F, Schockmel GA, Hirschel B, Fox CH, Pantaleo G.

J Infect Dis. 1998 Jun;177(6):1497-501.

PMID:
9607825
13.

Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infection.

Yerly S, Perneger TV, Vora S, Hirschel B, Perrin L.

AIDS. 2000 Dec 22;14(18):2805-12.

PMID:
11153661
14.

High levels of circulating RNA in patients with symptomatic HIV-1 infection.

Baumberger C, Kinloch-de-Loës S, Yerly S, Hirschel B, Perrin L.

AIDS. 1993 Nov;7 Suppl 2:S59-64.

PMID:
7909226
15.

Hemophilia and nonprogressing human immunodeficiency virus type 1 infection.

Vicenzi E, Bagnarelli P, Santagostino E, Ghezzi S, Alfano M, Sinnone MS, Fabio G, Turchetto L, Moretti G, Lazzarin A, Mantovani A, Mannucci PM, Clementi M, Gringeri A, Poli G.

Blood. 1997 Jan 1;89(1):191-200.

16.

Elevated plasma levels of lipopolysaccharide and high mobility group box-1 protein are associated with high viral load in HIV-1 infection: reduction by 2-year antiretroviral therapy.

Trøseid M, Nowak P, Nyström J, Lindkvist A, Abdurahman S, Sönnerborg A.

AIDS. 2010 Jul 17;24(11):1733-7. doi: 10.1097/QAD.0b013e32833b254d.

PMID:
20502315
17.

Retinal microangiopathy in human immunodeficiency virus infection is related to higher human immunodeficiency virus-1 load in plasma.

Furrer H, Barloggio A, Egger M, Garweg JG; Swiss HIV Cohort Study.

Ophthalmology. 2003 Feb;110(2):432-6.

PMID:
12578793
18.

Modifications of residual viraemia in human immunodeficiency virus-1-infected subjects undergoing repeated highly active antiretroviral therapy interruptions.

Palmisano L, Giuliano M, Bucciardini R, Andreotti M, Fragola V, Pirillo MF, Weimer LE, Mancini MG, Vella S.

J Med Microbiol. 2009 Jan;58(Pt 1):121-4. doi: 10.1099/jmm.0.004630-0.

PMID:
19074663
20.

Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years.

Günthard HF, Havlir DV, Fiscus S, Zhang ZQ, Eron J, Mellors J, Gulick R, Frost SD, Brown AJ, Schleif W, Valentine F, Jonas L, Meibohm A, Ignacio CC, Isaacs R, Gamagami R, Emini E, Haase A, Richman DD, Wong JK.

J Infect Dis. 2001 May 1;183(9):1318-27. Epub 2001 Apr 10.

PMID:
11294662

Supplemental Content

Support Center